Boston Scientific has recently reported the results of the Optical Coherence Tomography Drug Eluting Stent Investigation (OCTDESI)trial; part of the JACTAX stent program. [30] The JACTAX stent con ...

Boston Scientific reorganized its operational structure and aggregated its core businesses, each of which generates revenues from the sale of Medical Devices, into two reportable segments, MedSurg (38 ...

which includes our drug-eluting stents and our drug-coated balloon, is now growing close to double digits with drug-eluting stents at now less than 5%. That's less than 5% of our total company ...

This cohort will compare the Medtronic Prevail DCB with Boston Scientific AGENT DCB ... It will compare the Prevail DCB ...

Abbott, Boston Scientific ... treatment is the implantation of stents into the vessel. Ranging from bare metal to drug-eluting stents, a more recent growing approach for bioresorbable and polymer ...